2018年3月18日星期日

[HTML] NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity

[HTML] NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity

RJ AndersonBJ Compton, C Tang, A Authier-Hall… - Chemical …, 2015 - pubs.rsc.org
It is known that T cells can eliminate tumour cells through recognition of unique or aberrantly
expressed antigens presented as peptide epitopes by major histocompatibility complex
(MHC) molecules on the tumour cell surface. With recent advances in defining tumour-


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论